ESR1 and cancer: On the basis of previous basic research showing that S1P plays a pivotal role in estrogen-mediated signaling pathways in BC [28,36,37,38,39,40], we hypothesized that plasma S1P levels increase as the cancer progresses in estrogen receptor (ER)-positive BC patients.